All 56 State and Territory Attorneys General Ask Congress to Permanently Classify Fentanyl-Related Substances as Schedule I Drugs
Washington, D.C. — The National Association of Attorneys General (NAAG) sent a letter to Senate leadership, urging Congress to permanently classify fentanyl-related substances as Schedule I drugs. Schedule I drugs are defined as drugs with no currently accepted medical use and a high potential for abuse. All 56 state and territory attorneys general signed the letter asking Congress to…
NAAG Sends Letter to Congressional Leadership Urging Removal of Federal Barriers to Treat Opioid Use Disorder
Washington, D.C. — The National Association of Attorneys General (NAAG) has sent a letter to congressional leadership in both chambers, asking for the removal of federal barriers that are currently preventing health care providers from offering treatment for opioid use disorder. Opioid use disorder is the physical and psychological reliance on opioids. Symptoms of opioid addiction include uncontrollable…
Prosecuting Drug Overdose Cases: A Paradigm Shift
The number of overdose deaths in the United States has risen alarmingly; they are now the number one cause of accidental deaths. Investigating and prosecuting these deaths as homicides requires re-thinking how law enforcement handles these deaths and a thorough understanding of the laws supporting prosecuting the dealer who sold the drugs.
Attorneys General Support Federal Bill to Increase Access to Drug Addiction Treatment
Washington, D.C. — The National Association of Attorneys General (NAAG) is endorsing the federal bill, “Road to Recovery Act” (H.R. 2938) which will help address a lack of treatment for those suffering from drug addiction. The legislation will make treatment affordable for those who need it, and create market incentives for new treatment resources. America’s opioid…
Attorneys General Urge Health Insurance Companies to Reduce Provider Incentives for Prescribing Pain Killers
Washington, D.C.—The National Association of Attorneys General (NAAG) sent a letter today to America’s Health Insurance Plans (AHIP), asking its insurance company members to review payment and coverage policies and revise them, as needed, to encourage healthcare providers to choose alternatives to prescribing prescription pain relievers known as opioids. Opioid overdoses kill 91 Americans every…
Bridging the Gaps to Reduce Prescription Drug and Opioid Abuse and Misuse
While being in the throes of a national opioid abuse epidemic, a recently released NAGTRI report offers best and promising practices generated from a November 2016 Summit with law enforcement and public health officials. The link to a free website copy is provided.
“First, Do No Harm”: Criminal Prosecutions of Doctors for Distributing Controlled Substances Outside of Legitimate Medical Need
NAGTRI revisited a 2007 study on physicians who had been prosecuted for prescribing controlled substances. The goal of this project was to determine if there had been any shift in the numbers of prosecutions, patient addictions, or states issuing opioid prescription guidelines since the 2007 study in an effort to curb the opioid abuse epidemic across the country.
Managers as Caretakers: Rule 5.1
This is an ongoing column exploring various ethical topics relevant to attorneys general and other government attorneys. This issue addresses how managers can make reasonable efforts to ensure that the lawyers they supervise conduct themselves ethically. It notes that the legal profession is struggling with substance abuse and mental health issues in a much higher proportion than the general population.
The Effects of Marijuana Legalization on Employment Law
Twenty-six states and the District of Columbia have legalized marijuana in varying degrees in recent years. This article explores concerns most commonly faced by employers located in states which have legalized marijuana and provides suggestions for how employers can best navigate this landscape.
- « Previous
- 1
- 2
